Mangoceuticals Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 64/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Mangoceuticals Inc's Score
Industry at a Glance
Industry Ranking
64 / 78
Overall Ranking
499 / 4582
Industry
Healthcare Providers & Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Mangoceuticals Inc Highlights
StrengthsRisks
Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 6789.73% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 615.87K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 615.87K.
Overvalued
The company’s latest PE is 0.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 301.64K shares, decreasing 8.76% quarter-over-quarter.
Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Ticker SymbolMGRX
CompanyMangoceuticals Inc
CEOCohen (Jacob D)
Websitehttps://www.mangorx.com/
FAQs
What is the current price of Mangoceuticals Inc (MGRX)?
The current price of Mangoceuticals Inc (MGRX) is 0.713.
What is the symbol of Mangoceuticals Inc?
The ticker symbol of Mangoceuticals Inc is MGRX.
What is the 52-week high of Mangoceuticals Inc?
The 52-week high of Mangoceuticals Inc is 6.150.
What is the 52-week low of Mangoceuticals Inc?
The 52-week low of Mangoceuticals Inc is 0.980.
What is the market capitalization of Mangoceuticals Inc?
The market capitalization of Mangoceuticals Inc is 9.90M.
What is the net income of Mangoceuticals Inc?
The net income of Mangoceuticals Inc is -8.71M.
Is Mangoceuticals Inc (MGRX) currently rated as Buy, Hold, or Sell?
According to analysts, Mangoceuticals Inc (MGRX) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Mangoceuticals Inc (MGRX)?
The Earnings Per Share (EPS TTM) of Mangoceuticals Inc (MGRX) is 50.895.